EUVIMEDEUVIMED entdecken
Crossref

Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study

Hamid Reza Jahantigh, Behzad Shahbazi, Hamed Gouklai, Hans Van der Weken, Zahra Gharibi, Zahra Rezaei, Mehri Habibi, Khadijeh Ahmadi iD

Journal of Biomolecular Structure and Dynamics · 2023

DOI: 10.1080/07391102.2023.2201850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomolecular Structure and Dynamics, 2023. Verfasst von Hamid Reza Jahantigh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Department of Medicine - Section of Occupational Medicine, University of Bari, Bari, Italy. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monkeypox is a zoonotic virus that has recently affected different countries worldwide. On July 23, 2022, the WHO declared the outbreak of monkeypox as a public health emergency of international concern. Surveillance studies conducted in Central Africa in the 1980s and later during outbreaks in the same region showed smallpox vaccines to be clinically somewhat effective against Monkeypox virus. However, there is no specific vaccine against this virus. This research used bioinformatics techniques to establish a novel multi-epitope vaccine candidate against Monkeypox that can induce a strong immune response. Five well-known antigenic proteins (E8L, A30L, A35R, A29L, and B21R) of the virus were picked and assessed as possible immunogenic peptides. Two suitable peptide candidates were selected according to bio-informatics analysis. Based upon in silico evaluation, two multi-epitope vaccine candidates (ALALAR and ALAL) were built with rich-epitope domains consisting of high-ranking T and B-cell epitopes. After predicting and evaluating the 3D structure of the protein candidates, the most efficient 3D models were considered for docking studies with Toll-like receptor 4 (TLR4) and the HLA-A * 11:01, HLA-A*01:01, HLA-A*02:01, HLA-A*03:01, HLA-A*07:02, HLA-A*15:01, HLA-A*30:01 receptors. Subsequently, molecular dynamics (MD) simulation of up to 150 nanoseconds was employed to assess the durability of the interaction of the vaccine candidates with immune receptors. MD studies showed that M5-HLA-A*11:01, ALAL-TLR4, and ALALAR-TLR4 complexes were stable during simulation. Analysis of the in silico outcomes indicates that the M5 peptide and ALAL and ALALAR proteins may be suitable vaccine candidates against the Monkeypox virus.Communicated by Ramaswamy H. Sarma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mpox, MonkeypoxVaccinesHumansMonkeypox virusToll-Like Receptor 4VaccinologyPeptidesEpitopes, B-LymphocyteComputational BiologyMolecular Dynamics SimulationHLA-A AntigensMolecular Docking SimulationEpitopes, T-LymphocyteVaccines, Subunit

Stichwörter der Autor:innen

Monkeypoxepitopemolecular dynamicspredictionvaccine

Substanzen

Toll-Like Receptor 4PeptidesVaccinesEpitopes, B-LymphocyteHLA-A AntigensEpitopes, T-LymphocyteVaccines, Subunit

Autor:innen und Institutionen

  • Interdisciplinary Department of Medicine - Section of Occupational Medicine, University of Bari, Bari, Italy.
  • Animal Health and Zoonosis PhD Course, Department of Veterinary Medicine, University of Bari, Bari, Italy.
  • Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Laboratory of Immunology, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
  • Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Khadijeh Ahmadi

Zitieren

APA

Jahantigh, H. R., Shahbazi, B., Gouklai, H., Van der Weken, H., Gharibi, Z., Rezaei, Z., Habibi, M., & Ahmadi, K. (2023). Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2023.2201850

Vancouver

Jahantigh HR, Shahbazi B, Gouklai H, Van der Weken H, Gharibi Z, Rezaei Z, et al. Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study. Journal of Biomolecular Structure and Dynamics. 2023. doi:10.1080/07391102.2023.2201850

BibTeX
@article{Jahantigh2023,
  author = {Jahantigh, Hamid Reza and Shahbazi, Behzad and Gouklai, Hamed and Van der Weken, Hans and Gharibi, Zahra and Rezaei, Zahra and Habibi, Mehri and Ahmadi, Khadijeh},
  title = {Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study},
  journal = {Journal of Biomolecular Structure and Dynamics},
  year = {2023},
  doi = {10.1080/07391102.2023.2201850}
}
Kostenlos starten →